Grossman Adam S
President and CEO
Grossman Adam S has filed 10 SEC Form 4 filings (23 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Mar 17, 2026.
On the most recent filing, Grossman Adam S is listed as President and CEO at ADMA BIOLOGICS, INC. Inside the rolling window, Grossman Adam S reported no open-market purchases and 4 open-market sales totaling $1.4M in ADMA. The largest disclosed transaction in the window is a sale of 21,000 ADMA shares on Dec 15, 2025, worth $416K.
Companies traded
Other insiders at ADMA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 24, 2025 | ADMA | Sale | $96K |
| Oct 24, 2025 | ADMA | Sale | $240K |
| Sep 15, 2025 | ADMA | Sale | $97K |
| Sep 15, 2025 | ADMA | Sale | $242K |
Frequently asked questions
How many SEC Form 4 filings has Grossman Adam S made?
Grossman Adam S has filed 10 SEC Form 4 filings (23 transaction rows) across 1 company since 2025.
Which companies does Grossman Adam S trade?
Grossman Adam S has filed SEC Form 4 disclosures for 1 company, including ADMA.
When was Grossman Adam S's most recent SEC Form 4 filing?
Grossman Adam S's most recent SEC Form 4 filing on Tracefour is dated Mar 17, 2026.
What is Grossman Adam S's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Grossman Adam S is listed as President and CEO.
What is Grossman Adam S's total buy and sell value in the current window?
Inside the rolling retention window, Grossman Adam S bought $0 and sold $1.4M based on SEC Form 4 filings.
What was Grossman Adam S's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 21,000 ADMA shares on 2025-12-15, worth $416K, per SEC Form 4 filings.